Seroprevalence and presentation of SARS-CoV-2 in pregnancy
暂无分享，去创建一个
[1] Felipe García,et al. Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice , 2020, Fetal Diagnosis and Therapy.
[2] P. Brocklehurst,et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study , 2020, BMJ.
[3] Linda Y. Fu,et al. Planning for a COVID-19 Vaccination Program. , 2020, JAMA.
[4] A. Benachi,et al. Transplacental transmission of SARS-CoV-2 infection , 2020, Nature Communications.
[5] Russell S. Miller,et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals , 2020, American Journal of Obstetrics & Gynecology MFM.
[6] J. Hollander,et al. Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.
[7] M. Kris,et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment , 2017, JAMA.
[8] Amy P Abernethy,et al. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). , 2015, JAMA oncology.
[9] S. Rasmussen,et al. Pandemic Influenza and Pregnant Women , 2008, Emerging infectious diseases.